Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
side effects
Pharma
Neurocrine's Prader-Willi med tied to possible safety concerns
A year and a half after the approval of Vykat XR, clinicians connected to the Prader-Willi syndrome community are flagging potential safety concerns.
Fraiser Kansteiner
Aug 13, 2026 9:40am
HHS proposes creating table of COVID vaccine injuries
Jul 9, 2026 11:08am
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am
RFK Jr. continues to quietly probe vaccine safety: NYT
May 12, 2026 11:36am
CDC advisory panel sets new date for delayed vaccine meeting
Feb 26, 2026 2:28pm
Veru survey highlights muscle loss concerns among GLP-1 users
Jul 15, 2025 10:30am
